PharmaCyte Biotech Inc (PMCB)

[1234jklm]

They agreed to 10% and now its 50%


Austrianova will receive 50% of any other financial and non-financial consideration received from the Company’s sublicensees of the Cell-in-a-Box® technology.

We get the right to buy ciab but what if we can't afford it?

And even if we buy it they get 50% of anything we make from it.

But we already have a license and it's much better and cheaper.

We paid 2million for a license and now they want to dump it for something not as good.

It looks like Shareholders are getting screwed if this goes ahead.